|
Consolidated Statements of Operations (USD $)
In Millions, except Per Share data |
12 Months Ended | ||
|---|---|---|---|
|
Mar. 31, 2011
|
Mar. 31, 2010
|
Mar. 31, 2009
|
|
| Consolidated Statements of Operations [Abstract] | |||
| Net sales | $ 1,167.0 | $ 1,124.6 | $ 1,202.6 |
| Cost of goods sold | (775.1) | (708.5) | (813.8) |
| Gross profit | 391.9 | 416.1 | 388.8 |
| Selling, general and administrative expenses | (173.4) | (185.8) | (208.8) |
| Research and development expenses | (28.0) | (27.1) | (23.8) |
| Asbestos adjustments | (85.8) | (224.2) | 17.4 |
| Operating income (loss) | 104.7 | (21.0) | 173.6 |
| Interest expense | (9.0) | (7.7) | (11.2) |
| Interest income | 4.6 | 3.7 | 8.2 |
| Other (expense) income | (3.7) | 6.3 | (14.8) |
| Income (loss) before income taxes | 96.6 | (18.7) | 155.8 |
| Income tax expense | (443.6) | (66.2) | (19.5) |
| Net (loss) income | $ (347.0) | $ (84.9) | $ 136.3 |
| Net (loss) income per share - basic | $ (0.80) | $ (0.20) | $ 0.32 |
| Net (loss) income per share - diluted | $ (0.80) | $ (0.20) | $ 0.31 |
| Weighted average common shares outstanding (Millions): | |||
| Basic | 435.6 | 433.1 | 432.3 |
| Diluted | 435.6 | 433.1 | 434.5 |
| X | ||||||||||
|
- Definition
Comprised of changes in actuarial estimates received as of March 31 each year and the effect of foreign exchange movements in the asbestos related assets and liabilities which are denominated in Australian dollars.
|
| X | ||||||||||
|
- Definition
Total costs related to goods produced and sold during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The amount of net income or loss for the period per each share of common stock outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The amount of net income or loss for the period per each share of common stock and dilutive common stock equivalents outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.
|
| X | ||||||||||
|
- Definition
Sum of operating profit and nonoperating income (expense) before income (loss) from equity method investments, income taxes, extraordinary items, cumulative effects of changes in accounting principles, and noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The sum of the current income tax expense (benefit) and the deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The cost of borrowed funds accounted for as interest that was charged against earnings during the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Income derived from investments in debt securities and on cash and cash equivalents the earnings of which reflect the time value of money or transactions in which the payments are for the use or forbearance of money. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The portion of consolidated profit or loss for the period, net of income taxes, which is attributable to the parent. If the entity does not present consolidated financial statements, the amount of profit or loss for the period, net of income taxes. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The net result for the period of deducting operating expenses from operating revenues.
|
| X | ||||||||||
|
- Definition
The net amount of other nonoperating income and expense, which does not qualify for separate disclosure on the income statement under materiality guidelines. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Aggregate revenue during the period from the sale of goods in the normal course of business, after deducting returns, allowances and discounts. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The average number of shares issued and outstanding that are used in calculating diluted EPS, determined based on the timing of issuance of shares in the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Number of [basic] shares, after adjustment for contingently issuable shares and other shares not deemed outstanding, determined by relating the portion of time within a reporting period that common shares have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|